Cartesian Therapeutics, Inc. (RNAC)
7.64
+0.41
(+5.67%)
USD |
NASDAQ |
Jan 21, 16:00
7.70
+0.06
(+0.79%)
After-Hours: 20:00
Cartesian Therapeutics Total Liabilities (Quarterly): 408.52M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Repligen Corp. | 840.62M |
| Cabaletta Bio, Inc. | 50.29M |
| Arcellx, Inc. | 215.14M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.68M |
| Shareholders Equity (Quarterly) | -35.84M |
| Debt to Equity Ratio | -0.3516 |
| Current Ratio | 10.67 |
| Net Debt Paydown Yield | -0.16% |